"Preferred partner" —Dow
"One of five best" —Inc. Magazine
"Breakthrough business model" —National Academy of Sciences Institute of Medicine
Deal of Distinction —Licensing Executives Society
Patents for Humanity award —US Patent and Trademark Office
Legacy Award 2016 — East Bay Economic Development
Top University Worldwide in Number of Companies Founded by Undergraduate Alumni, and #2 for Female-founded Companies — Pitchbook
#1 Public University in the U.S. for Entrepreneurs with Graduate Degrees — PitchBook
$1B+ in Funds raised
including more than $1 Billion in Industry Sponsored Research and over $250M in Licensing Revenue.
825+ Products commercialized
from discoveries licensed through IPIRA such as of treatment for malaria and cancer, biofuels, robotic legs, DNA sequencing, surgical tools, forensic tools, handheld diagnostics, gene editing, mobile microscopy, nanowires, RFID, internet security software, search engines and more.
295+ Startups founded
to commercialize intellectual property rights under license from UC Berkeley. These companies have directly created more than 11,000 jobs, raised $3.3B over the last year, and attracted more than $31.3B in venture funding to date, as well as more than $51M in SBIR/STTR grants. 54 startups have had a successful exit via merger or acquisition, totaling more than $9.2B in cash and stock options, plus 25 startups have exited through an IPO.
1400+ Companies served
through negotiated agreements with IPIRA, including $500M in industry-sponsored research from British Petroleum for the Energy Biosciences Institute, >$5M in industry-sponsored research from Aduro, and $89M in licensing revenue from Bristol-Myers Squibb.
LEARN MORE
